Allurion Program News Today

Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences: Jefferies Global Healthcare...

Allurion Technologies (NYSE:ALUR – Get Free Report) is one of 224 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Allurion Technologies to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, dividends and institutional ownership. Insider and Institutional […]

Allurion Technologies Inc. (NYSE:ALUR – Free Report) – Equities research analysts at Chardan Capital increased their FY2024 earnings estimates for Allurion Technologies in a research report issued to clients and investors on Wednesday, May 15th. Chardan Capital analyst K. Nakae now expects that the company will earn ($0.44) per share for the year, up from […]

Chardan Capital reaffirmed their buy rating on shares of Allurion Technologies (NYSE:ALUR – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $5.00 price target on the stock. Separately, Jefferies Financial Group initiated coverage on shares of Allurion Technologies in a research report on Friday, February 9th. They […]

Generated quarter-over-quarter revenue growth and continued growth in procedural volume, while substantially reducing cash burn Company to report full first quarter 2024 financial results on May...

Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 629,700 shares, an increase of 116.0% from the March 31st total of 291,500 shares. Based on an average trading volume of 985,800 shares, the short-interest ratio […]

Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 629,700 shares, an increase of 116.0% from the March 31st total of 291,500 shares. Based on an average trading volume of 985,800 shares, […]

Virtual Care Suite is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy, bariatric surgery, and weight loss devices US product...

Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services Conference, taking...

Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced the appointment of its newest board member and Audit Committee Chair, Milena Alberti-Perez, effective as of March...